However, a small subset of APL patients have a different fusion gene, PLZF-RARA, resulting from the variant translocation t(11;17).     ///    Current data suggest that PML-RAR alpha and PLZF-RAR alpha fusion receptors may play an important role in the development of APL and that PML-RAR alpha could be the target of ATRA differentiation therapy. 